Press Releases

Date Title and Summary
Toggle Summary Accuray Receives FDA Clearance for New Dose Calculation Technique for Body Radiosurgery
Worldwide Availability of Monte Carlo Dose Calculation Software Announced at European Radiation Oncology Meeting in Barcelona BARCELONA, Spain, Sept. 10 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its Monte Carlo
Toggle Summary Accuray Board Approves Stock Repurchase Plan
SUNNYVALE, Calif., Aug. 30 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), today announced that its Board of Directors has approved a plan that authorizes the Company to repurchase shares of its common stock. Under the plan, the Company will have the ability to acquire up to $25
Toggle Summary Accuray Reports Record Revenue in Fiscal Fourth Quarter and Fiscal Year Ended 2007
Click here for PDF version of this release - Revenue Growth of 166 Percent Year Over Year - - Total Backlog Reaches Record Level of $619 Million - SUNNYVALE, Calif., Aug 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), the global leader in radiosurgery
Toggle Summary CyberKnife(R) System Extracranial Treatments Grow 75 Percent in Fiscal Year 2007 Demonstrating Radiosurgery Market Shift
U.S. Patients Treated with CyberKnife System for Lung Cancer Doubled and Prostate Cancer Quadrupled SUNNYVALE, Calif., Aug. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that use of its CyberKnife(R) Robotic
Toggle Summary Accuray's Xsight(TM) Lung Tracking System Gains Clinical Acceptance as U.S. Adoption Rate Exceeds 97 Percent
Monte Carlo Dose Calculation Extends CyberKnife(R) System's Capabilities in Precision Radiation Delivery for Lung Tumors SUNNYVALE, Calif., July 23 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Accuray's Xsight(TM)
Toggle Summary Accuray Incorporated to Report Fiscal Fourth Quarter and Full Fiscal Year 2007 Financial Results on August 16, 2007
SUNNYVALE, Calif., July 16, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced it will report results for its fourth quarter fiscal year 2007 ending June 30, 2007 and full fiscal year 2007 ending
Toggle Summary Accuray Incorporated to Present at Jefferies Healthcare Conference
SUNNYVALE, Calif., June 25 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Euan S. Thomson, Ph.D, president and chief executive officer and Robert E. McNamara, senior vice president and chief financial officer are
Toggle Summary 100 Percent of U.S. CyberKnife(R) Installed Base Treating Extracranial Tumors
Independent Data Confirms CyberKnife System is Only Radiosurgery Solution in Widespread Use for Extracranial Radiosurgery SUNNYVALE, Calif., June 20 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the latest utilization
Toggle Summary Multiple Hospitals Acquire Second CyberKnife(R) System to Meet Growing Demand for Radiosurgery
Second CyberKnife Arrives at Georgetown University Hospital SUNNYVALE, Calif., June 6 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Georgetown University Hospital's second CyberKnife(R) Robotic Radiosurgery System
Toggle Summary Health Technology Assessment Validates Extracranial Radiosurgery Treatments Particularly Those Delivered With CyberKnife(R)
French Health Authority Finds Clinical Benefits for Curative and Palliative Care SUNNYVALE, Calif., May 31 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that the French High Authority of Health -- Haute Autorite de Sante

*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.